Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor (Q42500633)

1 November 2017

title

Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor (English)

1 reference

1 November 2017

Kenneth A Iczkowski

1 reference

1 November 2017

Seakwoo Lee

1 reference

1 November 2017

Kevin K Desai

1 reference

1 November 2017

Robert G Newcomer

1 reference

1 November 2017

Kevin J Wu

1 reference

1 November 2017

Yun-Ge Zhao

1 reference

1 November 2017

Winston W Tan

1 reference

1 November 2017

Mark D Roycik

1 reference

1 November 2017

Qing-Xiang Amy Sang

1 reference

1 November 2017

publication date

1 September 2006

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

1 reference

1 November 2017

page(s)

750-758

1 reference

Matrix metalloproteinases: biologic activity and clinical implications

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

How matrix metalloproteinases regulate cell behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

New functions for the matrix metalloproteinases in cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Changing views of the role of matrix metalloproteinases in metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Identification and characterization of human endometase (Matrix metalloproteinase-26) from endometrial tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Characterization of matrix metalloproteinase-26, a novel metalloproteinase widely expressed in cancer cells of epithelial origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Peptide substrate specificities and protein cleavage sites of human endometase/matrilysin-2/matrix metalloproteinase-26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Activation of pro-gelatinase B by endometase/matrilysin-2 promotes invasion of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Endometase/matrilysin-2 in human breast ductal carcinoma in situ and its inhibition by tissue inhibitors of metalloproteinases-2 and -4: a putative role in the initiation of breast cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Primary structure and cDNA cloning of human fibroblast collagenase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Preparation and Characterization of Recombinant Tissue Inhibitor of Metalloproteinase 4 (TIMP-4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Analysis of prostate cancer by proteomics using tissue specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Unconventional activation mechanisms of MMP-26, a human matrix metalloproteinase with a unique PHCGXXD cysteine-switch motif

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

High-grade prostatic intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

Development and characterization of a new polyclonal antibody specifically against tissue inhibitor of metalloproteinases 4 in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

inferred from DOI database lookup

7 January 2021

based on heuristic

Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310089

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.CR.7310089

1 reference

Dimensions Publication ID

1 November 2017

1016152494

0 references

1 reference